Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Kelsey M Barcomb

TitlePost-Doctoral Fellow
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM - Pharmacology

    Collapse Research 
    Collapse research activities and funding
    F31NS083298     (BARCOMB, KELSEY MARIE)Dec 1, 2013 - May 31, 2015
    Mechanisms of CaMKII Binding to GluN2B and its Role in Synaptic Plasticity and Me
    Role: Principal Investigator

    F32DA043924     (BARCOMB, KELSEY MARIE)Apr 1, 2017 - Mar 31, 2020
    Circuit Specific Effects of Morphine on VTA Inhibitory Neuroplasticity
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Polter AM, Barcomb K, Tsuda AC, Kauer JA. Synaptic function and plasticity in identified inhibitory inputs onto VTA dopamine neurons. Eur J Neurosci. 2018 May; 47(10):1208-1218. PMID: 29480954.
      View in: PubMed
    2. Polter AM, Barcomb K, Chen RW, Dingess PM, Graziane NM, Brown TE, Kauer JA. Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress. Elife. 2017 04 12; 6. PMID: 28402252.
      View in: PubMed
    3. Barcomb K, Hell JW, Benke TA, Bayer KU. The CaMKII/GluN2B Protein Interaction Maintains Synaptic Strength. J Biol Chem. 2016 07 29; 291(31):16082-9. PMID: 27246855; PMCID: PMC4965558 [Available on 07/29/17].
    4. Barcomb K, Goodell DJ, Arnold DB, Bayer KU. Live imaging of endogenous Ca²?/calmodulin-dependent protein kinase II in neurons reveals that ischemia-related aggregation does not require kinase activity. J Neurochem. 2015 Nov; 135(4):666-73. PMID: 26212614; PMCID: PMC4636925 [Available on 11/01/16].
    5. Barcomb K, Buard I, Coultrap SJ, Kulbe JR, O'Leary H, Benke TA, Bayer KU. Autonomous CaMKII requires further stimulation by Ca2+/calmodulin for enhancing synaptic strength. FASEB J. 2014 Aug; 28(8):3810-9. PMID: 24843070; PMCID: PMC4101658.
    6. Barcomb K, Coultrap SJ, Bayer KU. Enzymatic activity of CaMKII is not required for its interaction with the glutamate receptor subunit GluN2B. Mol Pharmacol. 2013 Dec; 84(6):834-43. PMID: 24056996; PMCID: PMC3834147.
    7. Yamamoto DJ, Nelson AM, Mandt BH, Larson GA, Rorabaugh JM, Ng CM, Barcomb KM, Richards TL, Allen RM, Zahniser NR. Rats classified as low or high cocaine locomotor responders: a unique model involving striatal dopamine transporters that predicts cocaine addiction-like behaviors. Neurosci Biobehav Rev. 2013 Sep; 37(8):1738-53. PMID: 23850581; PMCID: PMC3810384.
    8. Coultrap SJ, Barcomb K, Bayer KU. A significant but rather mild contribution of T286 autophosphorylation to Ca2+/CaM-stimulated CaMKII activity. PLoS One. 2012; 7(5):e37176. PMID: 22615928; PMCID: PMC3353915.
    9. Saba LM, Bennett B, Hoffman PL, Barcomb K, Ishii T, Kechris K, Tabakoff B. A systems genetic analysis of alcohol drinking by mice, rats and men: influence of brain GABAergic transmission. Neuropharmacology. 2011 Jun; 60(7-8):1269-80. PMID: 21185315; PMCID: PMC3079014.
    Barcomb's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description

    Copyright © 2019 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)